BioMerieux Antibiotic Testing Platforms Win Awards
Posted July 31, 2006
DURHAM, N.C. — Two antibiotic testing platforms developed by
recently received market leadership awards from consulting firm Frost & Sullivan.
The VITEK 2 andVITEK 2 Compact platforms are used for infectious disease antibiotic susceptibility testing.
BioMerieux tests are now used in more than 60 percent of U.S.-based hospitals and most automated microbiological labs. The company received the Frost & Sullivan awards based on market share, revenue growth rate, profitability and innovative technology